Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Child

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
CMAJ Open|September 12, 2018
Growth hormone treatment of Canadian children: results from the GeNeSIS phase IV prospective observational studyCheri Deal, Susan Kirsch, Jean-Pierre Chanoine, et al.
European Journal of Endocrinology|January 30, 2013
Incidence of second neoplasm in childhood cancer survivors treated with GH: an analysis of GeNeSIS and HypoCCSWhitney W Woodmansee, Alan G Zimmermann, Christopher J Child, et al.
Clinical Diabetes : a Publication of the American Diabetes Association|November 16, 2022
Conversations and Reactions Around Severe Hypoglycemia (CRASH) Study: Results From People With Diabetes and Caregivers in the United StatesFrank J Snoek, Erik Spaepen, Barbara A Nambu, et al.
The Journal of Clinical Endocrinology and Metabolism|October 9, 2004
Continued growth hormone (GH) treatment after final height is necessary to complete somatic development in childhood-onset GH-deficient patientsAndrea F Attanasio, Elena Shavrikova, Werner F Blum, et al.
European Journal of Endocrinology|June 8, 2011
Assessment of primary cancers in GH-treated adult hypopituitary patients: an analysis from the Hypopituitary Control and Complications StudyChristopher J Child, Alan G Zimmermann, Whitney W Woodmansee, et al.
Diabetes, Obesity & Metabolism|May 3, 2026
Glycaemic Control According to the Final Insulin Dose Using an Innovative Fixed-Dose Titration of Weekly Insulin Efsitora in Insulin-Naïve Type 2 DiabetesLisa Connery, Julio Rosenstock, Neda Rasouli, et al.
European Journal of Endocrinology|February 19, 2016
Development of additional pituitary hormone deficiencies in pediatric patients originally diagnosed with isolated growth hormone deficiency due to organic causesChristopher J Child, Werner F Blum, Cheri Deal, et al.
Hormone Research in Paediatrics|June 12, 2019
Height Gain and Safety Outcomes in Growth Hormone-Treated Children with Idiopathic Short Stature: Experience from a Prospective Observational StudyChristopher J Child, Charmian A Quigley, Gordon B Cutler, et al.
Hormone Research in Paediatrics|May 22, 2013
Associations between pituitary imaging abnormalities and clinical and biochemical phenotypes in children with congenital growth hormone deficiency: data from an international observational studyCheri Deal, Caroline Hasselmann, Roland W Pfäffle, et al.
Clinical Therapeutics|September 19, 2019
Perceptions About Glucagon Delivery Devices for Severe Hypoglycemia: Qualitative Research With Patients, Caregivers, and AcquaintancesSanjay K Bajpai, M Janelle Cambron-Mellott, Eugenia Peck, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
CMAJ Open|September 12, 2018
Growth hormone treatment of Canadian children: results from the GeNeSIS phase IV prospective observational studyCheri Deal, Susan Kirsch, Jean-Pierre Chanoine, et al.
European Journal of Endocrinology|January 30, 2013
Incidence of second neoplasm in childhood cancer survivors treated with GH: an analysis of GeNeSIS and HypoCCSWhitney W Woodmansee, Alan G Zimmermann, Christopher J Child, et al.
Clinical Diabetes : a Publication of the American Diabetes Association|November 16, 2022
Conversations and Reactions Around Severe Hypoglycemia (CRASH) Study: Results From People With Diabetes and Caregivers in the United StatesFrank J Snoek, Erik Spaepen, Barbara A Nambu, et al.
The Journal of Clinical Endocrinology and Metabolism|October 9, 2004
Continued growth hormone (GH) treatment after final height is necessary to complete somatic development in childhood-onset GH-deficient patientsAndrea F Attanasio, Elena Shavrikova, Werner F Blum, et al.
European Journal of Endocrinology|June 8, 2011
Assessment of primary cancers in GH-treated adult hypopituitary patients: an analysis from the Hypopituitary Control and Complications StudyChristopher J Child, Alan G Zimmermann, Whitney W Woodmansee, et al.
Diabetes, Obesity & Metabolism|May 3, 2026
Glycaemic Control According to the Final Insulin Dose Using an Innovative Fixed-Dose Titration of Weekly Insulin Efsitora in Insulin-Naïve Type 2 DiabetesLisa Connery, Julio Rosenstock, Neda Rasouli, et al.
European Journal of Endocrinology|February 19, 2016
Development of additional pituitary hormone deficiencies in pediatric patients originally diagnosed with isolated growth hormone deficiency due to organic causesChristopher J Child, Werner F Blum, Cheri Deal, et al.
Hormone Research in Paediatrics|June 12, 2019
Height Gain and Safety Outcomes in Growth Hormone-Treated Children with Idiopathic Short Stature: Experience from a Prospective Observational StudyChristopher J Child, Charmian A Quigley, Gordon B Cutler, et al.
Hormone Research in Paediatrics|May 22, 2013
Associations between pituitary imaging abnormalities and clinical and biochemical phenotypes in children with congenital growth hormone deficiency: data from an international observational studyCheri Deal, Caroline Hasselmann, Roland W Pfäffle, et al.
Clinical Therapeutics|September 19, 2019
Perceptions About Glucagon Delivery Devices for Severe Hypoglycemia: Qualitative Research With Patients, Caregivers, and AcquaintancesSanjay K Bajpai, M Janelle Cambron-Mellott, Eugenia Peck, et al.
Pageof 4